![](/img/cover-not-exists.png)
405O_PR Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong
Loong, H.H., Wong, C.K.H., Leung, L.K.S., Leung, M.T.K., Wang, J., Stevinson, K.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw589.002
Date:
December, 2016
File:
PDF, 43 KB
english, 2016